Dimensional Fund Advisors LP Cyclacel Pharmaceuticals, Inc. Transaction History

Dimensional Fund Advisors LP

  • $376 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022
SELL
$6.1 - $7.15 $263,471 - $308,822
-43,192 Closed
0 $0
Q1 2022

May 13, 2022
SELL
$5.93 - $7.6 $8,533 - $10,936
-1,439 Reduced 3.22%
43,192 $132,000
Q4 2021

Feb 09, 2022
BUY
$6.04 - $8.03 $185,234 - $246,264
30,668 Added 219.64%
44,631 $173,000
Q3 2021

Nov 12, 2021
BUY
$8.02 - $11.0 $111,983 - $153,593
13,963 New
13,963 $74,000

About Cyclacel Pharmaceuticals, Inc.

CYCC Quotes by TradingView
  • Ticker CYCC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 12,539,200
  • Market Cap $7.9M
  • Description
  • Cyclacel Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer and other proliferative diseases. The company's development programs include fadraciclib, a cyclin dependent kinase Inhibitors (CDK) that is in Phase 1/2 clinical trial for the treatment of solid tumors, as well as in combin...
More about CYCC
Track This Portfolio

Track Dimensional Fund Advisors LP Portfolio

Follow Dimensional Fund Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email